Showing 1 - 10 of 47
Concern exists that public funding of science is increasingly risk averse. Funders have addressed this concern by soliciting the submission of high-risk research to either regular or specially designed programs. Little evidence, however, has been gathered to examine the extent to which such...
Persistent link: https://www.econbiz.de/10013361975
Operation Warp Speed (OWS) was a U.S. government-led program to accelerate the development, production, and administration of COVID-19 vaccines. The program cut the typical ten-year timeline needed to develop a new vaccine down to ten months and began vaccinating vulnerable populations within a...
Persistent link: https://www.econbiz.de/10015056157
This paper examines the regulation of technological innovation direction under uncertainty about potential harms. We …
Persistent link: https://www.econbiz.de/10014635704
literature on environmental innovation and diffusion, with a focus on studies relevant to the development of clean energy …
Persistent link: https://www.econbiz.de/10012462979
Irving Berlin and Cole Porter were two of the great experimental songwriters of the Golden Era. They aimed to create songs that were clear and universal. Their ability to do this improved throughout much of their careers, as their skill in using language to create simple and poignant images...
Persistent link: https://www.econbiz.de/10012463138
. Accordingly, this paper offers an empirical comparison of patents in relation to the award of prizes for technological innovation … unpredictable, and was unrelated to such proxies for the productivity of the innovation as inventive capital or the commercial …
Persistent link: https://www.econbiz.de/10012457935
The "market for innovation" -- the sale and licensing of patents -- is an often discussed source of incentives to … assumptions, allows us to quantify the gains resulting from the transfer of patents in the market for innovation. The gains from …
Persistent link: https://www.econbiz.de/10012461353
We derive the optimal funding mechanism to incentivize development and production of vaccines against diseases with epidemic potential. In the model, suppliers' costs are private information and investments are noncontractible, precluding cost-reimbursement contracts, requiring fixed-price...
Persistent link: https://www.econbiz.de/10013462668
We introduce new historical administrative data identifying U.S. government-funded patents since the early twentieth century. In addition to the funding agency, the data report whether the government has title to the patent ("title" patents) or funded a patent assigned to a private organization...
Persistent link: https://www.econbiz.de/10014486228
Recent efforts to endogenize technological change in climate policy models demonstrate the importance of accounting for the opportunity cost of climate R&D investments. Because the social returns to R&D investments are typically higher than the social returns to other types of investment, any...
Persistent link: https://www.econbiz.de/10012463226